Tag Archives: epidemic

Lily Gladstone Tears Up Describing the ‘Epidemic’ of Missing, Murdered Indigenous Women and Children and the Fight for Change – Variety

  1. Lily Gladstone Tears Up Describing the ‘Epidemic’ of Missing, Murdered Indigenous Women and Children and the Fight for Change Variety
  2. Leonardo DiCaprio Reacts To Lily Gladstone’s Audition Surprise Access Hollywood
  3. Leonardo DiCaprio calls ‘tremendous’ co-star Lily Gladstone ‘a voice of change’ The News International
  4. Leonardo DiCaprio Gives Speech Honoring Lily Gladstone’s Performance in ‘Killers of the Flower Moon’ Variety
  5. Lily Gladstone Tears Up Describing the ‘Epidemic’ of Missing, Murdered Indigenous Women and Children and the Fight for Change Yahoo Entertainment
  6. View Full Coverage on Google News

Read original article here

FACT SHEET: On Int’l Overdose Awareness Day, the Biden-Harris Administration Announces More Than $450 Million in New Funding to Support President Biden’s Unity Agenda Efforts to Beat the Overdose Epidemic and Save Lives – The White House

  1. FACT SHEET: On Int’l Overdose Awareness Day, the Biden-Harris Administration Announces More Than $450 Million in New Funding to Support President Biden’s Unity Agenda Efforts to Beat the Overdose Epidemic and Save Lives The White House
  2. Spotlight on Bay Area stories for National Overdose Awareness Day KPIX | CBS NEWS BAY AREA
  3. Alliance to Heal holds proclamation with City of La Crosse and La Crosse County WXOW.com
  4. Family of ‘Wire’ actor seeks to raise awareness of overdose danger Eyewitness News ABC7NY
  5. Overdose Awareness Day community event at MLK Center postponed WECT
  6. View Full Coverage on Google News

Read original article here

Texas is facing a housing crisis, a migrant crisis, a multi-year drought, and an epidemic of mass shootings. Ted Cruz, meanwhile, has opened an investigation into Bud Light. – Yahoo News

  1. Texas is facing a housing crisis, a migrant crisis, a multi-year drought, and an epidemic of mass shootings. Ted Cruz, meanwhile, has opened an investigation into Bud Light. Yahoo News
  2. LGBT group removes Anheuser-Busch from ‘Best Places to Work’ for not ‘standing by’ Mulvaney ad Fox Business
  3. Ted Cruz Launches Investigation Into Bud Light for Ad Featuring Transgender Influencer, Because No, He Doesn’t Have Anything Better to Do Vanity Fair
  4. Analysis | Ted Cruz figures out a way to guzzle new Bud Light headlines The Washington Post
  5. Sen. Ted Cruz calls for investigation into Bud Light’s partnership with Dylan Mulvaney The Cincinnati Enquirer
  6. View Full Coverage on Google News

Read original article here

Europe faces ‘cancer epidemic’ after estimated 1m cases missed during Covid | Cancer

Experts have warned that Europe faces a “cancer epidemic” unless urgent action is taken to boost treatment and research, after an estimated 1m diagnoses were missed during the pandemic.

The impact of Covid-19 and the focus on it has exposed “weaknesses” in cancer health systems and in the cancer research landscape across the continent, which, if not addressed as a matter of urgency, will set back cancer outcomes by almost a decade, leading healthcare and scientific experts say.

A report, European Groundshot – Addressing Europe’s Cancer Research Challenges: a Lancet Oncology Commission, brought together a wide range of patient, scientific, and healthcare experts with detailed knowledge of cancer across Europe.

One unintended consequence of the pandemic was the adverse effects that the rapid repurposing of health services and national lockdowns, and their continuing legacy, have had on cancer services, on cancer research, and on patients with cancer, the experts said.

“To emphasise the scale of this problem, we estimate that about 1m cancer diagnoses might have been missed across Europe during the Covid-19 pandemic,” they wrote in The Lancet Oncology. “There is emerging evidence that a higher proportion of patients are diagnosed with later cancer stages compared with pre-pandemic rates as a result of substantial delays in cancer diagnosis and treatment. This cancer stage shift will continue to stress European cancer systems for years to come.

“These issues will ultimately compromise survival and contribute to inferior quality of life for many European patients with cancer.”

The report analysed data and found clinicians saw 1.5 million fewer patients with cancer in the first year of the pandemic, with one in two patients with cancer not receiving surgery or chemotherapy in a timely manner. About 100m screenings were missed, and it is estimated that as many as 1 million European citizens may have an undiagnosed cancer as a result of the backlog.

“We estimate that approximately 1m cancer diagnoses were missed across Europe during the Covid-19 pandemic,” said Prof Mark Lawler, of Queen’s University Belfast, the chair and lead author of the commission. “We are in a race against time to find those missing cancers.

“Additionally, we saw a chilling effect on cancer research, with laboratories shut down and clinical trials delayed or cancelled in the first pandemic wave. We are concerned that Europe is heading towards a cancer epidemic in the next decade if cancer health systems and cancer research are not urgently prioritised.”

The Russia invasion of Ukraine represents another huge challenge to cancer research in Europe, the report says. Russia and Ukraine are two of the largest contributors to clinical cancer research in the world. The commission also predicts Brexit will negatively impact European cancer research.

“With the backdrop of the Covid-19 pandemic, Brexit, and the Russian invasion of Ukraine, it is more important than ever that Europe develops a resilient cancer research landscape to play a transformative role in improving prevention, diagnosis, treatment, and quality of life for current and future patients and those living beyond cancer,” said Lawler.

The report also argues that cancer prevention efforts and research, in particular, have not had the funding they deserve. A greater focus on preventing cancer would reduce the number of people who develop cancer and therefore allow more resources to be available for those who do require treatment, it says.

“It is estimated that 40% of cancers in Europe could be prevented if primary prevention strategies made better use of our current understanding of cancer risk factors,” said Anna Schmütz, of the International Agency for Research on Cancer.

Read original article here

Fentanyl Vaccine Breakthrough – Potential “Game Changer” for Opioid Epidemic

Researchers report the breakthrough discovery of a new vaccine that targets the dangerous synthetic opioid fentanyl. It can block fentanyl’s ability to enter the brain, thus eliminating the drug’s “high.”

Study suggests new vaccine could prevent deadly opioid from entering the brain.

A new vaccine has been developed that targets the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug’s “high.” The breakthrough discovery could have major implications for the nation’s opioid epidemic by becoming a relapse prevention agent for people trying to quit using opioids. While research reveals Opioid Use Disorder (OUD) is treatable, an estimated 80% of those dependent on the drug suffer a relapse. The vaccine was developed by a research team led by the University of Houston.

Published recently in the journal Pharmaceutics, the findings could not be timelier or more in demand: Over 150 people die every day from overdoses of synthetic opioids including fentanyl, which is 50 times stronger than heroin and 100 times stronger than morphine. Consumption of about 2 milligrams of fentanyl (the size of two grains of rice) is likely to be fatal depending on a person’s size.

Colin Haile, University of Houston research associate professor of psychology and the Texas Institute for Measurement, Evaluation and Statistics (TIMES), and a founding member of the UH Drug Discovery Institute. Haile is reporting a breakthrough fentanyl vaccine that could be a “game changer” in opioid addiction. Credit: University of Houston

“We believe these findings could have a significant impact on a very serious problem plaguing society for years – opioid misuse. Our vaccine is able to generate anti-fentanyl antibodies that bind to the consumed fentanyl and prevent it from entering the brain, allowing it to be eliminated out of the body via the kidneys. Thus, the individual will not feel the euphoric effects and can ‘get back on the wagon’ to sobriety,” said the study’s lead author Colin Haile, a research associate professor of psychology at UH and the Texas Institute for Measurement, Evaluation and Statistics (TIMES), and a founding member of the UH Drug Discovery Institute.

In another positive finding, the vaccine did not cause any adverse side effects in the immunized rats involved in lab studies. The team plans to start manufacturing clinical-grade vaccine in the coming months with clinical trials in humans planned soon.

Fentanyl is an especially dangerous threat because it is often added to street drugs like cocaine, methamphetamine and other opioids, such as oxycodone and hydrocodone/acetaminophen pills, and even to counterfeit benzodiazepines like Xanax. These counterfeit drugs laced with fentanyl add to the amount of fentanyl overdoses in individuals who do not ordinarily consume opioids.

In the lab: Therese Kosten, professor of psychology and director of the Developmental, Cognitive & Behavioral Neuroscience program and Colin Haile, research associate professor of psychology and the Texas Institute for Measurement, Evaluation and Statistics (TIMES), and a founding member of the UH Drug Discovery Institute. Credit: University of Houston

“The anti-fentanyl antibodies were specific to fentanyl and a fentanyl derivative and did not cross-react with other opioids, such as morphine. That means a vaccinated person would still be able to be treated for pain relief with other opioids,” said Haile.

The vaccine tested contains an adjuvant derived from E. coli named dmLT. An adjuvant molecule boosts the immune system’s response to vaccines, a critical component for the effectiveness of anti-addiction vaccines. The adjuvant was developed by collaborators at the Tulane University School of Medicine and has proven vital to the efficacy of the vaccine. Also on the team are Greg Cuny, Joseph P. & Shirley Shipman Buckley Endowed Professor of Drug Discovery at the UH College of Pharmacy along with researchers from Baylor College of Medicine and Michael E. DeBakey Veteran’s Affairs Medical Center.

Current treatments for OUD are methadone, buprenorphine and naltrexone, and their effectiveness depends upon formulation, compliance, access to medications and the specific misused opioid.

Therese Kosten, professor of psychology and director of the Developmental, Cognitive & Behavioral Neuroscience program at UH, calls the new vaccine a potential “game changer.”

“Fentanyl use and overdose is a particular treatment challenge that is not adequately addressed with current medications because of its pharmacodynamics and managing acute overdose with the short-acting naloxone is not appropriately effective as multiple doses of naloxone are often needed to reverse fentanyl’s fatal effects,” said Kosten, senior author of the study.

Reference: “An Immunconjugate Vaccine Alters Distribution and Reduces the Antinociceptive, Behavioral and Physiological Effects of Fentanyl in Male and Female Rats” by Colin N. Haile, Miah D. Baker, Sergio A. Sanchez, Carlos A. Lopez Arteaga, Anantha L. Duddupudi, Gregory D. Cuny, Elizabeth B. Norton, Thomas R. Kosten and Therese A. Kosten, 26 October 2022, Pharmaceutics.
DOI: 10.3390/pharmaceutics14112290

The study was funded by the Department of Defense through the Alcohol and Substance Abuse Disorders Program managed by RTI International’s Pharmacotherapies for Alcohol and Substance Use Disorders Alliance, which has funded Haile’s lab for several years to develop the anti-fentanyl vaccine.



Read original article here

A global epidemic of cancer among people younger than 50 could be emerging

Iana dos Reis Nunes (left) was 43 when she was diagnosed with colon cancer. A new review of cancer registry records from 44 countries found that the incidence of early-onset cancers is rising rapidly for colorectal and 13 other types of cancers. (Brendan Higgins via CNN)

Estimated read time: 7-8 minutes

NEW YORK — Iana dos Reis Nunes was 43 when she told her husband that she could feel something like a bubble in her abdomen when she lay on her side.

An ultrasound scan found spots on her liver, which led to blood tests and a colonoscopy.

“There was a tumor the size of your fist, and she had no pain and no problems with bowel movements or anything like that,” recalled Brendan Higgins, her husband, who works as an artist in New York City.

By the time doctors found it, dos Reis Nunes’ colon cancer had spread. It was stage 4, meaning it had reached other parts of her body.

The family was blindsided.

“She had had a baby 15 months prior to her diagnosis, so she’d had a million blood tests, you know, care from doctors and sonograms … and there was no indication of anything, nothing whatsoever.”

When cancer strikes an adult under the age of 50, doctors call it an early-onset case. These cancers at younger ages are becoming more common.

A new review of cancer registry records from 44 countries found that the incidence of early-onset cancers is rising rapidly for colorectal and 13 other types of cancers, many of which affect the digestive system, and this increase is happening across many middle- and high-income nations.

The review’s authors say the upswing in younger adults in happening in part because of more sensitive testing for some cancer types, such as thyroid cancer. But testing doesn’t completely account for the trend, says co-author Shuji Ogino, a professor of pathology at the Harvard T.H. Chan School of Public Health.

Ogino says the spike is due to an unhealthy stew of risk factors that are probably working together, some which are known and others that need to be investigated.

He notes that many of these risks have established links to cancer like obesity, inactivity, diabetes, alcohol, smoking, environmental pollution and Western diets high in red meat and added sugars, not to mention shift work and lack of sleep.

“And there are many unknown risk factors as well, like a pollutant or like food additives. Nobody knows,” he said.

Ogino thinks the fact that so many of these cancers — 8 out of 14 studied — involve the digestive system points to a big role for diet and the bacteria that live in our gut, called the microbiome.

“I think this actually is an important piece because what it’s pointing to is changing exposure prevalences at early ages, that are producing earlier-onset cancers,” says Dr. Elizabeth Platz, an epidemiologist at the Johns Hopkins Bloomberg School of Public Health who also edits the journal Cancer Epidemiology, Biomarkers & Prevention, who was not involved in the review.

Take obesity. Once, it was rare. Not only has it become more common to have a dangerously high body mass index, but people are becoming obese earlier in life, even in childhood, so these cancer risks are building decades earlier than they did for previous generations.

An explosion of colorectal cancer in younger adults

The surge in early-onset colorectal cancer — the cancer dos Reis Nunes had — has been particularly steep.

Ogino’s review found that across the years of the study, the average yearly climb in colorectal cancer in young adults was about 2% in the U.S., Australia, Canada, France and Japan. In the U.K., it’s almost 3% per year in England, Scotland and Wales. In Korea and Ecuador, it is roughly 5% per year.

“It doesn’t seem big, but you can think about inflation: If it’s 2% every year, it’s going to be a big change in 10 years or 20 years, you know?” Ogino said. “It’s not trivial.”

Between 1988 and 2015, those yearly upticks pushed the rates of early colorectal cancers from nearly 8 per 100,000 people to almost 13 per 100,000 — a 63% increase, according to another recent review published in The New England Journal of Medicine.

Studies show that about 1 in 10 colorectal cancers in the U.S. is diagnosed in someone who is between the ages of 20 and 50.

The younger you are, the higher the risk

Ogino’s review found something called a cohort effect, meaning the risk of an early-onset cancer has increased for each successive group of people born at a later time. Those born the 1990s have a higher risk of developing an early-onset cancer in their lifetime than those born in the 1980s, for example.

Other malignancies going up in younger Americans include those in the breast, endometrium, gallbladder and bile duct, kidney, pancreas, thyroid, stomach and plasma cells in the blood — a cancer called myeloma.

Dr. Karen Knudson, chief executive officer of the American Cancer Society, calls the review “a call to arms.”

Cancer is a serious diagnosis at any age, but when it shows up in younger adults, the tumors are typically more aggressive, and they often go undetected for longer because routine cancer screening isn’t recommended for some of the most common cancer types, such as breast and prostate, until age 50.

“Not only were these early-onset type of cancers more likely to be diagnosed when the tumor is at a more advanced stage, it was also in some of the reports that were tabulated here associated with worse survival outcome,” Knudson said.

‘Not an old person’s disease anymore’

Dos Reis Nunes started treatment in 2017 at Sloan Kettering and Mount Sinai cancer centers in New York.

Her husband remembers the doctors explaining that she was one of a growing number of younger patients they were seeing.

“I recall it being a point of discussion in both hospitals that people getting colon cancer were getting younger and younger, more and more, and they couldn’t explain it,” Higgins said.

Higgins says he spent a lot of time in online support groups, looking for answers and comfort.

“And there were a lot of young people in those groups,” he said. “It wasn’t populated by people in their 50s and 60s. It’s like 30s, 40s, 50s. So I was very conscious that this wasn’t an old person’s disease anymore,” he said.

In fact, routine screening — with colonoscopies and tests that check for blood in stool — has driven down cases of colorectal cancer and made it less fatal in older adults, even as cases have soared in those under 50.

Knudson says three things should happen in the wake of large, definitive reviews like this one.

“One is a call for research so that we truly do understand some of the specific trends that we are seeing,” she says.

Second, she wants to see more awareness of the risks, which will hopefully help people modify their behavior to control what risks they can.

Third, she says, groups that make recommendations for cancer screenings should re-evaluate when those screenings should start. It could be that some should start at younger ages.

In fact, that’s already happening.

Last year, the rising incidence of colon cancer in younger adults prompted the U.S. Preventive Services Task Force to lower the age at which it recommends doctors start screening people for colon cancer to 45.

“If you’re heading to 45, you should really be thinking about this and not waiting until 50 or 55,” Higgins said.

Higgins said his wife’s first 12 months of cancer treatment were almost miraculous, “like remarkable reactions to the chemo.”

“And then — I read about this actually — it can unravel really quickly,” he said. “And once it started unraveling, it just went downhill extremely quickly.”

His wife died in 2019, leaving behind their daughter, Maeve, who had not yet turned 4, an 11-year-old child and a 20-year-old child.

“We had a great love story,” he said. “I’m still bitter. Still angry.

“Life is OK. Everybody is fine. But I’m like, deep down, I’m seething that it happened to her. She was a really good person.”

Most recent Health stories

More stories you may be interested in

Read original article here

A global epidemic of cancer among people younger than 50 could be emerging



CNN
 — 

Iana dos Reis Nunes was 43 when she told her husband that she could feel something like a bubble in her abdomen when she lay on her side.

An ultrasound scan found spots on her liver, which led to blood tests and a colonoscopy.

“There was a tumor the size of your fist, and she had no pain and no problems with bowel movements or anything like that,” recalled Brendan Higgins, her husband, who works as an artist in New York City.

By the time doctors found it, dos Reis Nunes’ colon cancer had spread. It was stage 4, meaning it had reached other parts of her body.

The family was blindsided.

“She had had a baby 15 months prior to her diagnosis, so she’d had a million blood tests, you know, care from doctors and sonograms … and there was no indication of anything, nothing whatsoever.”

When cancer strikes an adult under the age of 50, doctors call it an early-onset case. These cancers at younger ages are becoming more common.

A new review of cancer registry records from 44 countries found that the incidence of early-onset cancers is rising rapidly for colorectal and 13 other types of cancers, many of which affect the digestive system, and this increase is happening across many middle- and high-income nations.

The review’s authors say the upswing in younger adults in happening in part because of more sensitive testing for some cancer types, such as thyroid cancer. But testing doesn’t completely account for the trend, says co-author Shuji Ogino, a professor of pathology at the Harvard T.H. Chan School of Public Health.

Ogino says the spike is due to an unhealthy stew of risk factors that are probably working together, some which are known and others that need to be investigated.

He notes that many of these risks have established links to cancer like obesity, inactivity, diabetes, alcohol, smoking, environmental pollution and Western diets high in red meat and added sugars, not to mention shift work and lack of sleep.

“And there are many unknown risk factors as well, like a pollutant or like food additives. Nobody knows,” he said.

Ogino thinks the fact that so many of these cancers – eight out of 14 studied – involve the digestive system points to a big role for diet and the bacteria that live in our gut, called the microbiome.

“I think this actually is an important piece because what it’s pointing to is changing exposure prevalences at early ages, that are producing earlier-onset cancers,” says Dr. Elizabeth Platz, an epidemiologist at the Johns Hopkins Bloomberg School of Public Health who also edits the journal Cancer Epidemiology, Biomarkers & Prevention, who was not involved in the review.

Take obesity. Once, it was rare. Not only has it become more common to have a dangerously high body mass index, but people are becoming obese earlier in life, even in childhood, so these cancer risks are building decades earlier than they did for previous generations.

The surge in early-onset colorectal cancer – the cancer dos Reis Nunes had – has been particularly steep.

Ogino’s review found that across the years of the study, the average yearly climb in colorectal cancer in young adults was about 2% in the US, Australia, Canada, France and Japan. In the UK, it’s almost 3% per year in England, Scotland and Wales. In Korea and Ecuador, it is roughly 5% per year.

“It doesn’t seem big, but you can think about inflation: If it’s 2% every year, it’s going to be a big change in 10 years or 20 years, you know?” Ogino said. “It’s not trivial.”

Between 1988 and 2015, those yearly upticks pushed the rates of early colorectal cancers from nearly 8 per every 100,000 people to almost 13 per 100,000 – a 63% increase, according to another recent review published in The New England Journal of Medicine.

Studies show that about 1 in 10 colorectal cancers in the US is diagnosed in someone who is between the ages of 20 and 50.

Ogino’s review found something called a cohort effect, meaning the risk of an early-onset cancer has increased for each successive group of people born at a later time. Those born the 1990s have a higher risk of developing an early-onset cancer in their lifetime than those born in the 1980s, for example.

Other malignancies going up in younger Americans include those in the breast, endometrium, gall bladder and bile duct, kidney, pancreas, thyroid, stomach and plasma cells in the blood – a cancer called myeloma.

Dr. Karen Knudson, chief executive officer of the American Cancer Society, calls the review “a call to arms.”

Cancer is a serious diagnosis at any age, but when it shows up in younger adults, the tumors are typically more aggressive, and they often go undetected for longer because routine cancer screening isn’t recommended for some of the most common cancer types, such as breast and prostate, until age 50.

“Not only were these early-onset type of cancers more likely to be diagnosed when the tumor is at a more advanced stage, it was also in some of the reports that were tabulated here associated with worse survival outcome,” Knudson said.

Dos Reis Nunes started treatment in 2017 at Sloan Kettering and Mount Sinai cancer centers in New York.

Her husband remembers the doctors explaining that she was one of a growing number of younger patients they were seeing.

“I recall it being a point of discussion in both hospitals that people getting colon cancer were getting younger and younger, more and more, and they couldn’t explain it,” Higgins said.

Higgins says he spent a lot of time in online support groups, looking for answers and comfort.

“And there were a lot of young people in those groups,” he said. “It wasn’t populated by people in their 50s and 60s. It’s like 30s, 40s, 50s. So I was very conscious that this wasn’t an old person’s disease anymore,” he said.

In fact, routine screening – with colonoscopies and tests that check for blood in stool – has driven down cases of colorectal cancer and made it less fatal in older adults, even as cases have soared in those under 50.

Knudson says three things should happen in the wake of large, definitive reviews like this one.

“One is a call for research so that we truly do understand some of the specific trends that we are seeing,” she says.

Second, she wants to see more awareness of the risks, which will hopefully help people modify their behavior to control what risks they can.

Third, she says, groups that make recommendations for cancer screenings should re-evaluate when those screenings should start. It could be that some should start at younger ages.

In fact, that’s already happening.

Last year, the rising incidence of colon cancer in younger adults prompted the US Preventive Services Task Force to lower the age at which it recommends doctors start screening people for colon cancer to 45.

“If you’re heading to 45, you should really be thinking about this and not waiting until 50 or 55,” Higgins said.

Higgins said his wife’s first 12 months of cancer treatment were almost miraculous, “like remarkable reactions to the chemo.”

“And then – I read about this actually – it can unravel really quickly,” he said. “And once it started unraveling, it just went downhill extremely quickly.”

His wife died in 2019, leaving behind their daughter, Maeve, who had not yet turned 4, an 11-year-old and a 20-year-old.

“We had a great love story,” he said. “I’m still bitter. Still angry.

“Life is OK. Everybody is fine. But I’m like, deep down, I’m seething that it happened to her. She was a really good person.”

Read original article here

Coronavirus cases: Research sheds light on an emerging parallel COVID epidemic amid new variant, lingering symptoms

LOS ANGELES — Because so many people have dealt with COVID-19 infections, many now view the virus like a common cold or flu.

New research suggests that’s far from the truth. With concern over COVID waning, a parallel pandemic is emerging.

READ MORE | Long COVID symptoms plague sufferers, but new studies could lead to treatments and relief

“We’re still learning about the long term health effects of COVID infections,” said Los Angeles County Public Health Director Barbara Ferrer.

Dr. Michael Ghobrial with the Cleveland Clinic said they’re seeing it more commonly in younger patients.

READ MORE | Long haul COVID in kids symptoms, lingering effects still poorly understood

This comes as doctors across the country are dealing with a growing number of patients who can’t shake their initial COVID symptoms or have acquired new symptoms that last for at least a month or more. Some cases have been going on for two years.

“The most described symptoms of long COVID include fatigue, reduced exercise capacity, breathing problems, brain fog and loss of taste or smell,” said Ferrer.

Various studies find long COVID, or long haulers syndrome, can strike in all populations.

READ MORE | Future uncertain for COVID ‘long-haulers’ struggling with chronic illness

“It’s more in females compared to males. It’s also more common in patients who have comorbidities,” said Ghobrial.

In a study of several thousand veterans, Ferrer said the new evidence suggests repeated COVID infections increase one’s risk for long haul syndrome.

“Many of these disorders were serious and life changing and included stroke, cognition and memory disorders, peripheral nervous system disorders,” she said. “The risk of having long term health conditions was three times higher for those infected three times compared to those who were uninfected.”

Avoiding infection is the key, and while COVID vaccines and boosters don’t always prevent infection, numerous studies find it can reduce the risk of long COVID.

“Those who had two doses of vaccine before getting COVID had an approximately 75% lower chance of getting long COVID,” said Ferrer. “While those who got three doses had an 84% lower chance of getting long COVID.”

While we have much to learn, Ferrer said getting vaccinated and boosted appears to be one of the simplest ways to significantly reduce your risk.

Copyright © 2022 KABC Television, LLC. All rights reserved.



Read original article here

Coronavirus cases: Research sheds light on an emerging parallel COVID epidemic amid new variant, lingering symptoms

LOS ANGELES — Because so many people have dealt with COVID-19 infections, many now view the virus like a common cold or flu.

New research suggests that’s far from the truth.

With concern over COVID waning, a parallel pandemic is emerging.

“We’re still learning about the long term health effects of COVID infections,” said Los Angeles County Public Health Director Barbara Ferrer.

SEE ALSO | 80% with long COVID have debilitating conditions: CDC

Dr. Michael Ghobrial with the Cleveland Clinic said they’re seeing it more commonly in younger patients.

This comes as doctors across the country are dealing with a growing number of patients who can’t shake their initial COVID symptoms or have acquired new symptoms that last for at least a month or more. Some cases have been going on for two years.

“The most described symptoms of long COVID include fatigue, reduced exercise capacity, breathing problems, brain fog and loss of taste or smell,” said Ferrer.

Various studies find long COVID, or long haulers syndrome, can strike in all populations.

“It’s more in females compared to males. It’s also more common in patients who have comorbidities,” said Ghobrial.

In a study of several thousand veterans, Ferrer said the new evidence suggests repeated COVID infections increase one’s risk for long haul syndrome.

RELATED | COVID US: CDC drops traveler health notices for individual countries

“Many of these disorders were serious and life changing and included stroke, cognition and memory disorders, peripheral nervous system disorders,” she said. “The risk of having long term health conditions was three times higher for those infected three times compared to those who were uninfected.”

Avoiding infection is the key, and while COVID vaccines and boosters don’t always prevent infection, numerous studies find it can reduce the risk of long COVID.

“Those who had two doses of vaccine before getting COVID had an approximately 75% lower chance of getting long COVID,” said Ferrer. “While those who got three doses had an 84% lower chance of getting long COVID.”

While we have much to learn, Ferrer said getting vaccinated and boosted appears to be one of the simplest ways to significantly reduce your risk.

Copyright © 2022 KABC Television, LLC. All rights reserved.



Read original article here

Coronavirus Los Angeles: New research sheds light on an emerging parallel COVID epidemic

LOS ANGELES (KABC) — Because so many residents in Los Angeles County have dealt with COVID-19 infections, many now view the virus like a common cold or flu.

New research suggests that’s far from the truth.

With concern over COVID waning, a parallel pandemic is emerging.

“We’re still learning about the long term health effects of COVID infections,” said L.A. County Public Health Director Barbara Ferrer.

Dr. Michael Ghobrial with the Cleveland Clinic said they’re seeing it more commonly in younger patients.

This comes as doctors across the country are dealing with a growing number of patients who can’t shake their initial COVID symptoms or have acquired new symptoms that last for at least a month or more. Some cases have been going on for two years.

“The most described symptoms of long COVID include fatigue, reduced exercise capacity, breathing problems, brain fog and loss of taste or smell,” said Ferrer.

Various studies find long COVID, or long haulers syndrome, can strike in all populations.

“It’s more in females compared to males. It’s also more common in patients who have comorbidities,” said Ghobrial.

In a study of several thousand veterans, Ferrer said the new evidence suggests repeated COVID infections increase one’s risk for long haul syndrome.

“Many of these disorders were serious and life changing and included stroke, cognition and memory disorders, peripheral nervous system disorders,” she said. “The risk of having long term health conditions was three times higher for those infected three times compared to those who were uninfected.”

Avoiding infection is the key, and while COVID vaccines and boosters don’t always prevent infection, numerous studies find it can reduce the risk of long COVID.

“Those who had two doses of vaccine before getting COVID had an approximately 75% lower chance of getting long COVID,” said Ferrer. “While those who got three doses had an 84% lower chance of getting long COVID.”

While we have much to learn, Ferrer said getting vaccinated and boosted appears to be one of the simplest ways to significantly reduce your risk.

Copyright © 2022 KABC Television, LLC. All rights reserved.



Read original article here